A detailed history of Axq Capital, LP transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Axq Capital, LP holds 13,314 shares of APLS stock, worth $442,157. This represents 0.12% of its overall portfolio holdings.

Number of Shares
13,314
Holding current value
$442,157
% of portfolio
0.12%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$28.84 - $41.15 $383,975 - $547,871
13,314 New
13,314 $384 Million
Q1 2024

May 14, 2024

BUY
$55.39 - $72.47 $382,191 - $500,043
6,900 New
6,900 $406 Million
Q2 2023

Aug 11, 2023

BUY
$76.68 - $93.31 $212,403 - $258,468
2,770 New
2,770 $252 Million

Others Institutions Holding APLS

About Apellis Pharmaceuticals, Inc.


  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.65B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Axq Capital, LP Portfolio

Follow Axq Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axq Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Axq Capital, LP with notifications on news.